EMILY LEE: Open Payments
NPI 1982234209 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 10 payments from 8 companies in 2025. Trend: 2023 $802 · 2024 $1,298 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $39 |
| Lundbeck LLC | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, REXULTI, FARXIGA, Sunosi, CAPLYTA, Kerendia, VRAYLAR, ZORYVE.
Industry payments across TN — which companies pay providers there.
